Digital/ Views & Analysis/ Views and analysis Digital health predicted as the new normal in COVID aftermath mike.hammerton@pharmaphorum.com Bayer, Bayer G4A, coronavirus, COVID-19, digital health, G4A 0 Comment There are few countries left unaffected by COVID-19 and solutions can’t seem to arrive soon enough. In the Share X Digital health predicted as the new normal in COVID aftermath https://pharmaphorum.com/views-analysis-digital/digital-health-predicted-as-the-new-normal-in-covid-aftermath/
Digital/ Views & Analysis/ Views and analysis Digital therapeutics start-ups need patience as well as patients mike.hammerton@pharmaphorum.com Bayer, digital therapeutics, G4A, start ups 0 Comment An entirely new category of medicine is emerging, and a new wave of digital therapeutics start-ups is joining Share X Digital therapeutics start-ups need patience as well as patients https://pharmaphorum.com/views-analysis-digital/bayer-g4a-digital-therapeutics-startups/
Digital/ Views & Analysis/ Views and analysis The sky’s the limit for the right digital health start-ups mike.hammerton@pharmaphorum.com Bayer, digital health, G4A, start ups, xbird 0 Comment What started out six years ago as a local ‘passion project’ for Bayer to collaborate with Berlin’s digital Share X The sky’s the limit for the right digital health start-ups https://pharmaphorum.com/views-analysis-digital/bayer-g4a-digital-health-startups/
Bayer, Bayer G4A, coronavirus, COVID-19, digital health, G4A
0 Comment
